Top Markets
Coin of the day
Alar Pharmaceuticals Inc. Alar Pharmaceuticals Inc.

Alar Pharmaceuticals Inc.

6785
Rank in Stocks #18601
Alar Pharmaceuticals Inc., a drug development company, focuses on developing... Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.
Share Price
$2.88
Market Cap
$192.66M
Change (1 day)
-0.55%
Change (1 year)
-59.61%
Country
TW
Trade Alar Pharmaceuticals Inc. (6785)

Category

Operating Margin for Alar Pharmaceuticals Inc. (6785)
Operating Margin as of 2026 TTM: 0.00%
According to Alar Pharmaceuticals Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Alar Pharmaceuticals Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
62.34% -
US
0.00% -
SE
0.00% -
FR
29.76% -
HK
0.00% -
IT
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.